Less Ads, More Data, More Tools Register for FREE

Pin to quick picksESKN.L Regulatory News (ESKN)

  • There is currently no data for ESKN

Directorate Change

9 Feb 2021 07:00

RNS Number : 3841O
Esken Limited
09 February 2021
 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

9 February 2021

Esken Limited

("Esken" or "the Company")

 

Directorate changes

 

Esken Limited, the aviation and energy infrastructure group, announces that Warwick Brady has tendered his resignation as Chief Executive and has accepted an offer to become Chief Executive of Swissport, a global aviation services business. It has been agreed with the Board that Warwick will remain as Chief Executive of Esken until the end of June at the latest. This will provide sufficient time to ensure continuity and a smooth transition in leadership. He will not be entitled to any payments other than his contractual entitlements for the period up to his leaving date.

 

David Shearer will assume the role of Executive Chairman on an interim basis with immediate effect. His initial priority will be to review Esken's strategic options as the Company navigates the continuing impact of the COVID-19 pandemic. As part of that exercise he will determine the leadership requirements for a new CEO to implement that strategy.

 

Esken owns two attractive core businesses; Stobart Energy, which supplies biomass fuel to renewable energy plants and London Southend Airport. Both businesses have the potential to generate significant value for shareholders in a post COVID world.

 

Executive Chairman David Shearer said, "I would like to thank Warwick for all of his efforts during his time as Chief Executive. He has led the transformation of Esken into an operationally focused business and was instrumental in establishing London Southend Airport as a key London Airport asset. In the last 12 months, he has dealt with the challenges which the business has experienced due to the COVID-19 pandemic. The board wishes him well in his new role.

 

All of Esken's businesses benefit from strong experienced operational management teams with the capabilities required to take the business forward. I look forward to working with Lewis Girdwood, Nick Dilworth and all of our people and stakeholders as we navigate the recovery into the post COVID period."

 

Chief Executive Warwick Brady added, "It has been a privilege to lead this business over the past four years. I am grateful for the support of my highly dedicated and professional colleagues. Esken is a strong company with great people and I wish David and the team every success."

 

 The Group will announce a trading update for the year ending February 2021 in March.

 

Enquiries:

 

Esken Limited

Charlie Geller, Communications Director

C/O Tulchan Communications

 

 

Tulchan Communications 

Olivia Peters/David Allchurch

 

 

020 7353 4200

esken@tulchangroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWURRAVUURUR
Date   Source Headline
28th Mar 20241:05 pmRNSCancellation of listing
21st Mar 20245:05 pmRNSConfirmation of appointment of administrators
21st Mar 20248:59 amRNSIntention to appoint administrators to the Company
18th Mar 20244:35 pmRNSUpdate on Exchangeable Bonds
12th Mar 20248:53 amRNSTR-1
6th Mar 20247:00 amRNSUpdate on the future of the Company
5th Mar 20247:00 amRNSUpdate on LSA & Carlyle Global Infrastructure Fund
19th Feb 20247:00 amRNSUpdate on LSA & Carlyle Global Infrastructure Fund
5th Feb 20247:00 amRNSUpdate on LSA & Carlyle Global Infrastructure Fund
23rd Jan 20247:00 amRNSUpdate on LSA & Carlyle Global Infrastructure Fund
12th Jan 202410:40 amRNSTR-1
12th Jan 20247:00 amRNSTR-1
21st Dec 20238:42 amRNSTransfer to standard listing
15th Dec 20235:45 pmRNSEsken
13th Dec 20233:41 pmRNSTR1
13th Dec 202310:03 amRNSTR-1
12th Dec 20233:41 pmRNSTR-1
12th Dec 20232:47 pmRNSTR-1
1st Dec 202312:43 pmRNSCompletion of disposal of Esken Renewables
29th Nov 20237:00 amRNSHalf-year Report
24th Nov 20235:13 pmRNSEGM Results and Further Updates
6th Nov 20235:45 pmRNSPublication of Circular and Notice of EGM
6th Nov 20237:00 amRNSHolding(s) in Company
1st Nov 20238:38 amRNSProposed Disposal of Esken Renewables
31st Oct 20237:00 amRNSResponse to press speculation
2nd Oct 20239:56 amRNSTR-1
28th Sep 20237:00 amRNSTR-1
26th Sep 20237:00 amRNSLSA and Carlyle Global Infrastructure Fund
30th Aug 20232:02 pmRNSResults of AGM
30th Aug 20237:00 amRNSAGM Update
4th Aug 20233:17 pmRNSPosting of Annual Report and Notice of AGM
3rd Aug 20235:03 pmRNSSale of investment in Mersey Bioenergy
25th Jul 20237:00 amRNSDirectorate Change
21st Jun 20237:01 amRNSTR-1
21st Jun 20237:00 amRNSFinal Results
20th Jun 20237:00 amRNSDisposal
16th Jun 20237:00 amRNSNotice of Results
15th May 202310:16 amRNSShare sale of Star Handling
21st Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
2nd Mar 20237:00 amRNSTrading Statement
23rd Feb 20234:35 pmRNSPrice Monitoring Extension
2nd Feb 20237:00 amRNSTrading Statement
30th Jan 20234:35 pmRNSPrice Monitoring Extension
18th Jan 20234:35 pmRNSPrice Monitoring Extension
17th Jan 20237:00 amRNSAirline agreement
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.